Latest University of California, San Francisco Stories
A new study from the University of California, San Francisco (UCSF) reveals that treating patients with cells may one day become as common as it is now to treat the sick with drugs from engineered proteins, antibodies, or smaller chemicals.
The immune system's T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources.
It's a basic, reasonable question: How much will this cost me?
Over a span of nearly 20 years, California's tobacco control program cost $2.4 billion and reduced health care costs by $134 billion.
Scientists from the University of California, San Francisco (UCSF) recently conducted a study that showed a significantly earlier onset of menopause for women who inherited a mutation in one of the breast cancer susceptibility gene (BRCA) genes.
The spread of breast cancer to distant organs within the body, an event that often leads to death, appears in many cases to involve the loss of a key protein.
Technological advancements in medicine have allowed patients suffering from musculoskeletal conditions such as hip and knee pain to regain mobility and live relatively pain-free.
- A volcanic mudflow.